These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 12746896)

  • 41. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
    De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
    Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritis.
    Juurikivi A; Sandler C; Lindstedt KA; Kovanen PT; Juutilainen T; Leskinen MJ; Mäki T; Eklund KK
    Ann Rheum Dis; 2005 Aug; 64(8):1126-31. PubMed ID: 16014680
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High synovial expression of the inhibitory FcgammaRIIb in rheumatoid arthritis.
    Magnusson SE; Engström M; Jacob U; Ulfgren AK; Kleinau S
    Arthritis Res Ther; 2007; 9(3):R51. PubMed ID: 17521421
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transforming growth factor beta 1(TGF-beta1) down-regulates TNFalpha-induced RANTES production in rheumatoid synovial fibroblasts through NF-kappaB-mediated transcriptional repression.
    Cho ML; Min SY; Chang SH; Kim KW; Heo SB; Lee SH; Park SH; Cho CS; Kim HY
    Immunol Lett; 2006 Jun; 105(2):159-66. PubMed ID: 16564576
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interleukin (IL)-23 p19 expression induced by IL-1beta in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-kappaB and AP-1 dependent pathway.
    Liu FL; Chen CH; Chu SJ; Chen JH; Lai JH; Sytwu HK; Chang DM
    Rheumatology (Oxford); 2007 Aug; 46(8):1266-73. PubMed ID: 17569750
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LIGHT is involved in the pathogenesis of rheumatoid arthritis by inducing the expression of pro-inflammatory cytokines and MMP-9 in macrophages.
    Kim WJ; Kang YJ; Koh EM; Ahn KS; Cha HS; Lee WH
    Immunology; 2005 Feb; 114(2):272-9. PubMed ID: 15667572
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Hepburn AL; Mason JC; Davies KA
    Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells.
    Roelofs MF; Joosten LA; Abdollahi-Roodsaz S; van Lieshout AW; Sprong T; van den Hoogen FH; van den Berg WB; Radstake TR
    Arthritis Rheum; 2005 Aug; 52(8):2313-22. PubMed ID: 16052591
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extravasation into synovial tissue induces CCL20 mRNA expression in polymorphonuclear neutrophils of patients with rheumatoid arthritis.
    Schlenk J; Lorenz HM; Haas JP; Herrmann M; Hohenberger G; Kalden JR; Röllinghoff M; Beuscher HU
    J Rheumatol; 2005 Dec; 32(12):2291-8. PubMed ID: 16331752
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression.
    Kitano M; Hla T; Sekiguchi M; Kawahito Y; Yoshimura R; Miyazawa K; Iwasaki T; Sano H; Saba JD; Tam YY
    Arthritis Rheum; 2006 Mar; 54(3):742-53. PubMed ID: 16508938
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression and proinflammatory role of proteinase-activated receptor 2 in rheumatoid synovium: ex vivo studies using a novel proteinase-activated receptor 2 antagonist.
    Kelso EB; Ferrell WR; Lockhart JC; Elias-Jones I; Hembrough T; Dunning L; Gracie JA; McInnes IB
    Arthritis Rheum; 2007 Mar; 56(3):765-71. PubMed ID: 17328048
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis.
    Nakashima-Matsushita N; Homma T; Yu S; Matsuda T; Sunahara N; Nakamura T; Tsukano M; Ratnam M; Matsuyama T
    Arthritis Rheum; 1999 Aug; 42(8):1609-16. PubMed ID: 10446858
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Soluble vascular cell adhesion molecule 1 mediation of monocyte chemotaxis in rheumatoid arthritis.
    Tokuhira M; Hosaka S; Volin MV; Haines GK; Katschke KJ; Kim S; Koch AE
    Arthritis Rheum; 2000 May; 43(5):1122-33. PubMed ID: 10817567
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes.
    Zhu P; Lu N; Shi ZG; Zhou J; Wu ZB; Yang Y; Ding J; Chen ZN
    Arthritis Res Ther; 2006; 8(2):R44. PubMed ID: 16507143
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study.
    Baslund B; Tvede N; Danneskiold-Samsoe B; Larsson P; Panayi G; Petersen J; Petersen LJ; Beurskens FJ; Schuurman J; van de Winkel JG; Parren PW; Gracie JA; Jongbloed S; Liew FY; McInnes IB
    Arthritis Rheum; 2005 Sep; 52(9):2686-92. PubMed ID: 16142748
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promote osteoclastogenesis in autologous monocytes.
    Miranda-Carús ME; Benito-Miguel M; Balsa A; Cobo-Ibáñez T; Pérez de Ayala C; Pascual-Salcedo D; Martín-Mola E
    Arthritis Rheum; 2006 Apr; 54(4):1151-64. PubMed ID: 16575870
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.
    Nakahara H; Song J; Sugimoto M; Hagihara K; Kishimoto T; Yoshizaki K; Nishimoto N
    Arthritis Rheum; 2003 Jun; 48(6):1521-9. PubMed ID: 12794819
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Augmented production of chemokines by the interaction of type II collagen-reactive T cells with rheumatoid synovial fibroblasts.
    Min DJ; Cho ML; Lee SH; Min SY; Kim WU; Min JK; Park SH; Cho CS; Kim HY
    Arthritis Rheum; 2004 Apr; 50(4):1146-55. PubMed ID: 15077296
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium.
    Bramlage CP; Kaps C; Ungethüm U; Bramlage P; Koziolek M; Wessels J; Krenn V; Pruss A; Müller GA; Strutz F; Burmester GR; Häupl T
    Scand J Rheumatol; 2008; 37(6):401-9. PubMed ID: 18830904
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effectiveness of anti-folate receptor beta antibody conjugated with truncated Pseudomonas exotoxin in the targeting of rheumatoid arthritis synovial macrophages.
    Nagayoshi R; Nagai T; Matsushita K; Sato K; Sunahara N; Matsuda T; Nakamura T; Komiya S; Onda M; Matsuyama T
    Arthritis Rheum; 2005 Sep; 52(9):2666-75. PubMed ID: 16142741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.